Differential diagnosis of optic-spinal multiple sclerosis variant and Devic's disease among Mongoloid race representatives

Bibliography:
1. Lublin FD, Reingold SC, Cohen JA, Cutter GR. Defining the clinical course of multiple sclerosis. Neurology 2014 Jul 15; 83 (3): 278-286
2. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003 Feb; 2 (2): 117-27
3. Yoshimura S, Isobe N, Yonekawa T, et al. Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients. PLoS One2012;7(11):e48592
4. Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007 May; 130 (Pt5): 1206-23
5. Tanaka K, Tani T, Tanaka M, et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 2007 Aug; 13 (7): 850-5
6. Matsushita T, Isobe N, Matsuoka T, et al. Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult Scler 2009 Jul; 15 (7): 834-47
7. Ishizu T, Kira J, Osoegawa M, et al. Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey. J Neurol Sci 2009 May 15; 280 (1-2): 22-8
8. Minurova AR, Okoneshnikova LT, Popova ТЕ, et al. Clinical and epidemiological peculiarities of multiple sclerosis in Yakut. Journal of Neurology and Psychiatry n.a. S. S. Korsakov 2007; (4): 14-22
9. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006 May 23; 66 (10): 1485-9. 10. Schmidt ТЕ. Treatment and differential diagnosis of multiple sclerosis and neuromyelitis optica (based on the 29th Congress of ECTRIMS). Journal of Neurology 2014; 19 (2): 53-62
11. Trebst С, Jarius S, Berthele A, et al. Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 2014; 261 (1): 1-16.